ROMA (Reminiscence, Reality Orientation, Music and Art ) Therapy, Cognition, Depression and Behavioral Problems in the Population With Dementia

March 18, 2022 updated by: Huang, Hui-Chuan, Taipei Medical University

The Effect of ROMA Therapy on Improving Cognitive Functions, Depressive Symptoms and Behavioral Problems in the Population With Dementia

This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in population with dementia. The hypotheis of this study is that these patients with dementia receiving ROMA therapy featuring reminiscence, reality orientation, music, and art would improve their cognition, depressive symptoms, and behavioral symptoms.

Study Overview

Detailed Description

This study aimed to conduct a randomized controlled trial to examine the effectiveness of ROMA therapy( Reminiscence, Reality Orientation, Music, and Art) on improving cognitive function, behavioral and psychological symptoms in demented population. A total of 60 patients with mild to moderate dementia will be recruited and randomly assigned to two groups: experimental group and control group. The experimental group will undergo ROMA therapy with a 60 minute per week for eight weeks. The control group will receive three times ROMA therapy after completing outcome measurements. Two groups will receive questionnaire interview at pre-test, post-test, and at 4 weeks after intervention. The measurements comprises: Short Portable Mental Status Questionnaire(SPMSQ), Cornell Scale for Depression in Dementia(CSDD),and Neuropsychiatric Inventory-Questionnaire(NPI-Q). By identifying the effectiveness of ROMA therapy, suitable intervention can be suggested for those demented population to improve cognitive function, behavioral and psychological symptoms.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • New Taipei City, Taiwan, 234
        • Yonghe Zhongxing Public Seniors Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

63 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Been diagnosed as mild to moderate dementia and CDR score between 0.5~2
  2. can communicate in Chinese or Taiwanese
  3. without visual or auditory impairment after equipping assist devices

Exclusion Criteria:

  1. severe dementia and Clinical Dementia Rating (CDR) score more than 2 points
  2. functional dependence
  3. incapable of expressing their feelings

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
usual care
Experimental: ROMA therapy
ROMA therapy combines four elements including reminiscence, reality orientation, music, and art in the intervention.
An intervention comprising reminiscence of annual festivals, orientation, and familiar music listening and singing, and animation interaction to improve cognitive functions, depressive symptoms and behaviors problems.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cognitive functions
Time Frame: cognitive functions at baseline
Short Portable Mental Status Questionnaire(SPMSQ)
cognitive functions at baseline
cognitive functions
Time Frame: cognitive functions after the completion of intervention
Short Portable Mental Status Questionnaire(SPMSQ)
cognitive functions after the completion of intervention
cognitive functions
Time Frame: cognitive functions at 4 weeks after the completion of intervention
Short Portable Mental Status Questionnaire(SPMSQ)
cognitive functions at 4 weeks after the completion of intervention
depressive symptoms
Time Frame: depressive symptoms at baseline
Cornell Scale for Depression in Dementia(CSDD)
depressive symptoms at baseline
depressive symptoms
Time Frame: depressive symptoms after the completion of intervention
Cornell Scale for Depression in Dementia(CSDD)
depressive symptoms after the completion of intervention
depressive symptoms
Time Frame: depressive symptoms at 4 weeks after the completion of intervention
Cornell Scale for Depression in Dementia(CSDD)
depressive symptoms at 4 weeks after the completion of intervention
behavioral problems
Time Frame: behavioral problems at baseline
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
behavioral problems at baseline
behavioral problems
Time Frame: behavioral problems after the completion of intervention
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
behavioral problems after the completion of intervention
behavioral problems
Time Frame: behavioral problems at 4 weeks after the completion of intervention
Neuropsychiatric Inventory-Questionnaire(NPI-Q)
behavioral problems at 4 weeks after the completion of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hui-Chuan Huang, PhD, School of Nursing, Taipei Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 25, 2020

Primary Completion (Actual)

July 30, 2021

Study Completion (Actual)

July 31, 2021

Study Registration Dates

First Submitted

July 25, 2020

First Submitted That Met QC Criteria

August 9, 2020

First Posted (Actual)

August 11, 2020

Study Record Updates

Last Update Posted (Actual)

March 21, 2022

Last Update Submitted That Met QC Criteria

March 18, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on ROMA therapy(reminiacence therpy, orientation, music, and art)

3
Subscribe